Highlights and Quick Summary
- Annual 10Y Shareholders Equity Growth (per Share) for 2021 was 0.0% (a NaN% decrease from previous year)
- Annual 10Y Shareholders Equity Growth (per Share) for 2020 was 0.0% (a NaN% decrease from previous year)
Visit stockrow.com/BCRX
for comprehensive keystats, realtime prices, income statement, balance sheet, cash flow
statement with 10 years of data, and state-of-the-art screener.
Historical 10Y Shareholders Equity Growth (per Share) of BioCryst Pharmaceuticals, Inc.
Most recent 10Y Shareholders Equity Growth (per Share)of BCRX including historical data for past 10 years.Interactive Chart of 10Y Shareholders Equity Growth (per Share) of BioCryst Pharmaceuticals, Inc.
BioCryst Pharmaceuticals, Inc. 10Y Shareholders Equity Growth (per Share) for the past 10 Years (both Annual and Quarterly)
| Year | Q1 | Q2 | Q3 | Q4 | Fiscal Year |
|---|---|---|---|---|---|
| 2021 | – | – | – | – | 0.0% |
| 2020 | – | – | – | – | 0.0% |
| 2019 | – | – | – | – | 0.0% |
Business Profile of BioCryst Pharmaceuticals, Inc.
Sector: Healthcare
Industry: Biotechnology